Anterix | 8-K: FY2027 Q1 Revenue Misses Estimate at USD 1.958 M

Revenue: As of FY2027 Q1, the actual value is USD 1.958 M, missing the estimate of USD 1.979 M.

EPS: As of FY2027 Q1, the actual value is USD 0.01, beating the estimate of USD -0.1653.

EBIT: As of FY2027 Q1, the actual value is USD -231 K.

Financial and Operational Highlights

Anterix Inc. reported approximately $33.1 million in contracted proceeds outstanding, with over $15.7 million received from customers during the first quarter of fiscal year 2027 and an additional $9.6 million expected during the remainder of fiscal year 2027. The company entered into a 10 MHz 900 MHz spectrum license sale agreement with Benton PUD for a total contract price of $0.8 million on April 16, 2026. Anterix Inc. also recorded a $10.653 million gain on the exchange of broadband licenses after exchanging narrowband for broadband licenses in six counties. Investments in spectrum clearing costs amounted to $6.7 million.

Consolidated Statements of Operations (Three months ended June 30, 2026 vs. 2025)

Spectrum Revenue

• 2026: $1.958 million.
• 2025: $1.418 million.

Operating Expenses

• Total Operating Expenses: $12.856 million in 2026, a decrease from $13.806 million in 2025.
• General and administrative expenses: $9.624 million in 2026, down from $10.449 million in 2025.
• Sales and support expenses: $1.911 million in 2026, up from $1.493 million in 2025.
• Product development expenses: $1.220 million in 2026, up from $1.120 million in 2025.
• Severance and other related charges: $0 in 2026, compared to $0.620 million in 2025.
• Depreciation and amortization: $0.101 million in 2026, down from $0.124 million in 2025.

Other Income and Expenses

• Gain on exchange of intangible assets, net: - $10.653 million in 2026, compared to - $33.916 million in 2025.
• Gain on sale of intangible assets, net: $0 in 2026, compared to - $0.961 million in 2025.
• Loss from disposal of long-lived assets, net: $0.001 million in 2026, down from $0.008 million in 2025.

(Loss) Income from Operations

• 2026: - $0.246 million.
• 2025: $22.481 million.

Interest Income

• 2026: $0.845 million.
• 2025: $0.442 million.

Other Income

• 2026: $0.015 million.
• 2025: $0.

Net Income

• 2026: $0.240 million.
• 2025: $25.180 million.

Consolidated Statements of Cash Flows (Three months ended June 30, 2026 vs. 2025)

Net Cash Provided by (Used in) Operating Activities

• 2026: $2.045 million provided.
• 2025: - $3.140 million used.

Net Cash Used in Investing Activities

• 2026: - $6.739 million.
• 2025: - $2.665 million.

Net Cash Provided by (Used in) Financing Activities

• 2026: $19.951 million provided.
• 2025: - $0.642 million used.

Net Change in Cash and Cash Equivalents and Restricted Cash

• 2026: $15.257 million increase.
• 2025: - $6.447 million decrease.

Cash and Cash Equivalents and Restricted Cash at End of Period

• June 30, 2026: $119.920 million.
• June 30, 2025: $48.577 million.

Liquidity and Balance Sheet (as of June 30, 2026)

Anterix Inc. reported no debt and held $116.0 million in cash and cash equivalents, along with a restricted cash balance of $3.9 million in escrow deposits. The company’s authorized share repurchase program allows for up to $250.0 million of common stock repurchases, with $226.7 million remaining available as of June 30, 2026; no share repurchase activity occurred in the first quarter of fiscal year 2027.

Consolidated Balance Sheets (as of June 30, 2026 vs. March 31, 2026)

Cash and cash equivalents

• June 30, 2026: $116.010 million.
• March 31, 2026: $98.533 million.

Total assets

• June 30, 2026: $497.925 million.
• March 31, 2026: $465.210 million.

Total liabilities

• June 30, 2026: $212.131 million.
• March 31, 2026: $202.889 million.

Total stockholders’ equity

• June 30, 2026: $285.794 million.
• March 31, 2026: $262.321 million.